Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis

HS. Choi, T. Won, X. Hou, G. Chen, W. Bracamonte-Baran, MV. Talor, I. Jurčová, O. Szárszoi, L. Čurnova, I. Stříž, JE. Hooper, V. Melenovský, D. Čiháková

. 2020 ; 30 (9) : 2989-3003.e6. [pub] 20200303

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21012811

Grant support
R01 HL118183 NHLBI NIH HHS - United States
R01 HL136586 NHLBI NIH HHS - United States

We find that cardiac group 2 innate lymphoid cells (ILC2s) are essential for the development of IL-33-induced eosinophilic pericarditis. We show a pathogenic role for ILC2s in cardiac inflammation, in which ILC2s activated by IL-33 drive the development of eosinophilic pericarditis in collaboration with cardiac fibroblasts. ILCs, not T and B cells, are required for the development of pericarditis. ILC2s transferred to the heart of Rag2-/-Il2rg-/- mice restore their susceptibility to eosinophil infiltration. Moreover, ILC2s direct cardiac fibroblasts to produce eotaxin-1. We also find that eosinophils reside in the mediastinal cavity and that eosinophils transferred to the mediastinal cavity of eosinophil-deficient ΔdblGATA1 mice following IL-33 treatment migrate to the heart. Thus, the serous cavities may serve as a reservoir of cardiac-infiltrating eosinophils. In humans, patients with pericarditis show higher amounts of ILCs in pericardial fluid than do healthy controls and patients with other cardiac diseases. We demonstrate that ILCs play a critical role in pericarditis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012811
003      
CZ-PrNML
005      
20210507101854.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.celrep.2020.02.040 $2 doi
035    __
$a (PubMed)32130902
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Choi, Hee Sun $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
245    10
$a Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis / $c HS. Choi, T. Won, X. Hou, G. Chen, W. Bracamonte-Baran, MV. Talor, I. Jurčová, O. Szárszoi, L. Čurnova, I. Stříž, JE. Hooper, V. Melenovský, D. Čiháková
520    9_
$a We find that cardiac group 2 innate lymphoid cells (ILC2s) are essential for the development of IL-33-induced eosinophilic pericarditis. We show a pathogenic role for ILC2s in cardiac inflammation, in which ILC2s activated by IL-33 drive the development of eosinophilic pericarditis in collaboration with cardiac fibroblasts. ILCs, not T and B cells, are required for the development of pericarditis. ILC2s transferred to the heart of Rag2-/-Il2rg-/- mice restore their susceptibility to eosinophil infiltration. Moreover, ILC2s direct cardiac fibroblasts to produce eotaxin-1. We also find that eosinophils reside in the mediastinal cavity and that eosinophils transferred to the mediastinal cavity of eosinophil-deficient ΔdblGATA1 mice following IL-33 treatment migrate to the heart. Thus, the serous cavities may serve as a reservoir of cardiac-infiltrating eosinophils. In humans, patients with pericarditis show higher amounts of ILCs in pericardial fluid than do healthy controls and patients with other cardiac diseases. We demonstrate that ILCs play a critical role in pericarditis.
650    _2
$a zvířata $7 D000818
650    _2
$a pohyb buněk $x účinky léků $7 D002465
650    _2
$a chemokin CCL11 $x genetika $x metabolismus $7 D054413
650    _2
$a náchylnost k nemoci $7 D004198
650    _2
$a eozinofily $x účinky léků $x patologie $7 D004804
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblasty $x účinky léků $x metabolismus $7 D005347
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a srdce $x účinky léků $x patofyziologie $7 D006321
650    _2
$a funkční vyšetření srdce $x účinky léků $7 D006334
650    _2
$a lidé $7 D006801
650    12
$a přirozená imunita $x účinky léků $7 D007113
650    _2
$a interleukin-1 receptor-like 1 protein $x nedostatek $x metabolismus $7 D000072179
650    _2
$a interleukin 33 $x farmakologie $7 D000067596
650    _2
$a interleukin-5 $x metabolismus $7 D015848
650    _2
$a lymfocyty $x účinky léků $x imunologie $7 D008214
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mediastinum $x patologie $7 D008482
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a perikarditida $x genetika $x imunologie $x patofyziologie $7 D010493
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a upregulace $x účinky léků $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Won, Taejoon $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Hou, Xuezhou $u W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Chen, Guobao $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Bracamonte-Baran, William $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Talor, Monica V $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Jurčová, Ivana $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Szárszoi, Ondrej $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Čurnova, Lenka $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Stříž, Ilja $u Department of Clinical and Transplant Immunology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Hooper, Jody E $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Čiháková, Daniela $u Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: cihakova@jhmi.edu
773    0_
$w MED00188029 $t Cell reports $x 2211-1247 $g Roč. 30, č. 9 (2020), s. 2989-3003.e6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32130902 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101854 $b ABA008
999    __
$a ok $b bmc $g 1651056 $s 1133190
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 30 $c 9 $d 2989-3003.e6 $e 20200303 $i 2211-1247 $m Cell reports $n Cell Rep $x MED00188029
GRA    __
$a R01 HL118183 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 HL136586 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Archiving options